Yes. They are just a tiddler. But they can still afford to pay UNS $10-$20m a year and their cash position will only get better from sales of this main drug of theirs.
1 down. 80+ to come!
Just an appetizer to the main course.
Add to My Watchlist
What is My Watchlist?